AbCheck Announces Collaboration to Apply Microfluidics Technology to the Discovery of Antibodies Against Challenging Therapeutic Neurology Target

February 21, 2023

https://www.globenewswire.com/news-release/2023/02/21/2611804/0/en/AbCheck-Announces-Collaboration-to-Apply-Microfluidics-Technology-to-the-Discovery-of-Antibodies-Against-Challenging-Therapeutic-Neurology-Target.html

PLZEN, Czech Republic, Feb. 21, 2023 (GLOBE NEWSWIRE) — AbCheck s.r.o., a technology company delivering disruptive antibody discovery and development solutions for challenging targets, announced today that it has entered into a collaboration with a biotech company developing antibodies targeting peripheral neural response, funded by a top-tier European Venture Capital firm.

Read more at globenewswire.com

Related news for (AFMD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.